Tariffs on Medicines From Europe Stand to Cost Drugmakers Billions

The New York Times – Business:

Many pharmaceutical products made in Europe will face a 15 percent tariff, pinching manufacturers and potentially leading to higher drug prices.

This post first appeared in The New York Times – Business. Read the original article.